Why choose Herts?

Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.

Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.

Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.

 

About the course

The use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.